Raising Awareness, Driving Action

This past year was an exciting and consequential time in the fight against Alzheimer's Disease. Read more about our efforts in this year's Annual Report.

Say Hello to BrainGuide

Our platform BrainGuide™ empowers people of all ages and communities to understand and take action on brain health and Alzheimer's disease.

The Brain Health Academy

Free, evidence-based courses to equip healthcare and wellness providers with the knowledge and resources to help people reduce the risk of dementia and Alzheimer’s. Next Session: Sleep and Dementia, August 17

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

The fight to end Alzheimer’s got a major boost today as the U.S. House Appropriations Committee passed significant funding increases for Alzheimer’s research, prevention, and treatment.

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

UsAgainstAlzheimer’s chair and co-founder George Vradenburg submitted public comment to Centers for Medicare and Medicare Services (CMS) urging the agency to reconsider their National Coverage Determination (NCD) and provide coverage without CED for the FDA-approved use of amyloid-beta PET scan.

New Survey: Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

A new A-LIST® survey of people with Alzheimer’s and Alzheimer’s caregivers shows that 75 percent want Medicare to cover new therapies—even after they are told that the drugs have a risk of side effects and still require confirmatory trials.

The 2021 Annual Report

Say Hello to BrainGuide

The Brain Health Academy

Major Win for Alzheimer’s Patients as U.S. House Committee Announces Significant Investments in Fighting Alzheimer’s

UsAgainstAlzheimer’s Urges CMS to Reconsider Rule Limiting Access to PET Scans

Three in Four in Alzheimer’s Community Want Medicare to Cover Alzheimer’s Treatments

UsAgainstAlzheimer's: Working to End Alzheimer's Disease  

The Alzheimer’s pandemic is one of the most significant health and social economic crises of this generation. It is a national and global emergency that has a devastating health, social and economic toll on millions of people living with this disease, their families and caregivers.

UsAgainstAlzheimer’s exists to conquer Alzheimer’s disease. Since our founding in 2010, we have taken on the toughest problems in the fight to end Alzheimer’s. Our work is driven by the urgency to find effective treatments and the prevention steps needed to reach the time where no one is lost to Alzheimer’s.

We bring all of “Us” together to:

In the past decade, progress has been made, with more hope on the horizon now than ever before.

But every day of delay is another day lost to the millions of people affected by this devastating disease. If nothing changes, by 2050, 14 million Americans will be living with Alzheimer’s at an annual cost of more than $1 trillion. The time to act is now.

Recent News and Blog Posts

  • February 09, 2022

    Coalition Letter: 35 Diverse Health Advocacy Organizations Urge CMS to Prioritize Equity & Access to Alzheimer's Treatments

    The Health Equity Collaborative, together with UsAgainstAlzheimer’s, led a coalition letter to...

    Read more
  • February 09, 2022

    More Than 50 Leading Patient Organizations Send Letter Calling on Medicare to Revise Proposed National Coverage Determination

    More than 50 patient advocacy groups urged Health and Human Services Secretary Xavier Becerra to direct...

    Read more
  • February 02, 2022

    Doctors, Scientists and Patient Advocates Call for Medicare to Cover Alzheimer’s Treatments

    The draft proposal by the Centers for Medicare and Medicaid Services...

    Read more
  • January 27, 2022

    UsAgainstAlzheimer’s Welcomes Biogen’s 18 Percent Diversity Goal for U.S. Participants in Aduhelm Confirmatory Trial

    “This is an important step forward in ensuring that people of color...

    Read more
  • January 26, 2022

    UsAgainstAlzheimer’s Letter to HHS Secretary Becerra: Direct CMS to Reconsider its Draft Decision on Medicare Coverage for Alzheimer’s Drugs

    Patient advocacy group UsAgainstAlzheimer’s today urged Health and Human Services Secretary Xavier...

    Read more
  • January 19, 2022

    Myth vs. Fact: CMS Draft Decision on Alzheimer’s Drugs

    With so much misinformation surrounding the draft National Coverage Determination (NCD) from...

    Read more

Reports

  • Resources

    A-LIST Pulse of the Community - December 2021

  • Resources

    2020 Annual Report

    In these pages, you will find highlights of the game-changing accomplishments and tremendous progress of UsAgainstAlzheimer's and our partners in the year of 2020. 

  • Resources
    Thumbnail

    Place & Brain Health Equity: Understanding the County-Level Impacts of Alzheimer’s

    The effects of where people live, and the social determinants of health are under-recognized and under-appreciated in our national response to effectively treat and prevent Alzheimer’s. This report found that...